These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 33008265)
1. Current immunosuppressive and antifibrotic therapies of systemic sclerosis and emerging therapeutic strategies. Fallet B; Walker UA Expert Rev Clin Pharmacol; 2020 Nov; 13(11):1203-1218. PubMed ID: 33008265 [TBL] [Abstract][Full Text] [Related]
2. New promising drugs for the treatment of systemic sclerosis: pathogenic considerations, enhanced classifications, and personalized medicine. Lescoat A; Varga J; Matucci-Cerinic M; Khanna D Expert Opin Investig Drugs; 2021 Jun; 30(6):635-652. PubMed ID: 33909517 [No Abstract] [Full Text] [Related]
3. Antifibrotics in systemic sclerosis. Martin-Lopez M; Carreira PE Best Pract Res Clin Rheumatol; 2021 Sep; 35(3):101671. PubMed ID: 33839046 [TBL] [Abstract][Full Text] [Related]
4. Emerging drugs for the treatment of scleroderma: a review of recent phase 2 and 3 trials. Roofeh D; Lescoat A; Khanna D Expert Opin Emerg Drugs; 2020 Dec; 25(4):455-466. PubMed ID: 33054463 [TBL] [Abstract][Full Text] [Related]
5. Current treatment options in systemic Sclerosis (Scleroderma). Stummvoll GH Acta Med Austriaca; 2002; 29(1):14-9. PubMed ID: 11899748 [TBL] [Abstract][Full Text] [Related]
6. Interstitial lung disease in systemic sclerosis: current and future treatment. Giacomelli R; Liakouli V; Berardicurti O; Ruscitti P; Di Benedetto P; Carubbi F; Guggino G; Di Bartolomeo S; Ciccia F; Triolo G; Cipriani P Rheumatol Int; 2017 Jun; 37(6):853-863. PubMed ID: 28063071 [TBL] [Abstract][Full Text] [Related]
11. Molecular and cellular pathways as treatment targets for biologic therapies in systemic sclerosis. Dimitroulas T; Daoussis D; Garyfallos A; Sfikakis PP; Kitas GD Curr Med Chem; 2015; 22(16):1943-55. PubMed ID: 25850767 [TBL] [Abstract][Full Text] [Related]
12. Nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease. Yamasaki Y; Kuwana M Expert Rev Clin Immunol; 2020 Jun; 16(6):547-560. PubMed ID: 32506975 [TBL] [Abstract][Full Text] [Related]
13. Emerging drugs and therapeutics for systemic sclerosis. Lee JJ; Pope JE Expert Opin Emerg Drugs; 2016 Dec; 21(4):421-430. PubMed ID: 27813423 [TBL] [Abstract][Full Text] [Related]
14. The power of the EUSTAR cohort: key findings to date and implications for management of systemic sclerosis patients. Benvenuti F; Zanatta E; Avouac J; Müller-Ladner U; Cozzi F; Hoffmann-Vold AM; Gabrielli A; Distler O; Matucci-Cerinic M; Allanore Y; Doria A Expert Rev Clin Immunol; 2020 Nov; 16(11):1065-1074. PubMed ID: 33076716 [TBL] [Abstract][Full Text] [Related]
16. Current and future perspectives on management of systemic sclerosis-associated interstitial lung disease. Distler O; Volkmann ER; Hoffmann-Vold AM; Maher TM Expert Rev Clin Immunol; 2019 Oct; 15(10):1009-1017. PubMed ID: 31566449 [No Abstract] [Full Text] [Related]
17. Drug development and novel therapeutics to ensure a personalized approach in the treatment of systemic sclerosis. Farina N; Campochiaro C; Lescoat A; Benanti G; De Luca G; Khanna D; Dagna L; Matucci-Cerinic M Expert Rev Clin Immunol; 2023; 19(9):1131-1142. PubMed ID: 37366065 [TBL] [Abstract][Full Text] [Related]
18. New therapeutic strategies for systemic sclerosis--a critical analysis of the literature. Zandman-Goddard G; Tweezer-Zaks N; Shoenfeld Y Clin Dev Immunol; 2005 Sep; 12(3):165-73. PubMed ID: 16295521 [TBL] [Abstract][Full Text] [Related]
19. Guidelines for clinical trials in systemic sclerosis (scleroderma). I. Disease-modifying interventions. The American College of Rheumatology Committee on Design and Outcomes in Clinical Trials in Systemic Sclerosis. White B; Bauer EA; Goldsmith LA; Hochberg MC; Katz LM; Korn JH; Lachenbruch PA; LeRoy EC; Mitrane MP; Paulus HE Arthritis Rheum; 1995 Mar; 38(3):351-60. PubMed ID: 7880189 [TBL] [Abstract][Full Text] [Related]
20. Update on disease-modifying antirheumatic drugs in the treatment of systemic sclerosis. Lin AT; Clements PJ; Furst DE Rheum Dis Clin North Am; 2003 May; 29(2):409-26. PubMed ID: 12841302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]